Key Takeaways:
JP Morgan is bullish on Chinese insurers, naming Ping An Insurance (02318.HK) and China Life (02628.HK) as its top sector picks following a strong first quarter.
"The reserve balances of major insurers demonstrated relative resilience compared with December 2022, suggesting a positive outlook for core earnings growth," JP Morgan said in a research report dated May 5. The bank highlighted robust core solvency ratios for the sector.
The broker assigned an "Overweight" rating to both Ping An and China Life, setting price targets of HKD90 and HKD40, respectively. The positive view is shared by other analysts, with Morgan Stanley also naming Ping An its top pick and raising its target to HKD92, citing strengthening fundamentals.
This renewed confidence follows a period where Chinese life insurers resumed disclosing their "residual margin," a key indicator of future profitability under new IFRS 17 accounting standards. For the first quarter of 2026, major life and non-life insurers posted robust core solvency, averaging 139% and 195%, respectively.
The bullish calls from JP Morgan and Morgan Stanley reflect a broader consensus that the Chinese insurance industry is on solid footing. According to Morgan Stanley's report, both life and property insurance businesses performed exceptionally in the first quarter. The firm noted a favorable equity market outlook and stable interest rates as factors that could provide further upside in the second quarter.
Ping An, in particular, has been recognized for its use of proprietary technology to enhance cross-selling across its finance, automotive, healthcare, and eldercare ecosystems. This strategy is expected to support stronger long-term growth compared to its peers.
The positive ratings signal that major investment banks see value in the sector after a period of adjustment to new accounting rules. For investors, these price targets suggest significant potential upside, and they will be watching for second-quarter results to confirm if the growth momentum continues.
This article is for informational purposes only and does not constitute investment advice.
